Clement Chung

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

The Annals of pharmacotherapy

Blood and lymphatic cancer : targets and therapy

JCO oncology practice

Houston Methodist West Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Houston Methodist West Hospital

United States

Oncology clinical pharmacy specialist :: Pharmacy

Publications

Clement Chung, Godsfavour Oghenero Umoru
Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Clement Chung, Godsfavour Oghenero Umoru, Karen Abboud, Eleanor Hobaugh
Sequencing and combination of current small-molecule inhibitors for chronic lymphocytic leukemia: Where is the evidence? European journal of haematology (2023)
Clement Chung, Alison Rome, Monica Desai, Fred Abanonu, Cesar De la Casas
Optimizing Multidisciplinary Treatment-Related Adverse Effects Detection and Reduction in Patients Undergoing Active Cancer Treatments in Ambulatory Infusion Centers. JCO oncology practice 18 (9) (2022)
Clement Chung
A Promising Future for Precision Epigenetic Therapy for Follicular and Diffuse Large B-Cell Lymphoma? Blood and lymphatic cancer : targets and therapy 12 (2022)
Clement Chung, Vanessa T Y Yeung, Kenneth C W Wong
Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendations. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Clement Chung
Predictive and prognostic biomarkers with therapeutic targets in colorectal cancer: A 2021 update on current development, evidence, and recommendation. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Clement Chung
Targeting the Myeloid Lineages and the Immune Microenvironment in Myelodysplastic Syndromes: Novel and Evolving Therapeutic Strategies. The Annals of pharmacotherapy (2021)
Clement Chung
New Therapeutic Targets and Treatment Options for Thrombotic Microangiopathy: Caplacizumab and Ravulizumab. The Annals of pharmacotherapy 55 (3) (2020)
Clement Chung
Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (4) (2020)

Clement Chung.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Clement Chung